Latest news with #WHOGMP
Time of India
25-06-2025
- Business
- Time of India
This Vadodara-based MSME is transforming food manufacturing in India
Live Events Food ingredient and nutraceutical manufacturers are critical to the food industry, developing everything from vitamin premixes that fortify cereal to stabilisers that make perishables last longer than they otherwise would. Their expertise in food science and regulatory compliance allows smaller manufacturers to access sophisticated ingredients and technologies without investing in expensive research and development (R&D). By standardising ingredient quality and functionality, these companies enable food producers to enhance flavours, extend shelf life, meet nutritional requirements, and maintain product consistency across different seasons and India, Sudeep Nutrition Pvt Ltd stands at the forefront of innovation in this sector. Founded in 2021 as a subsidiary of Sudeep Pharma Pvt Ltd, it has emerged as a transformative force in the country's nutrition and food processing landscape. With a legacy that spans over three decades through its parent company, Sudeep Nutrition has created a reliable foundation for small businesses seeking to upgrade manufacturing capabilities and enter premium market company operates from a state‑of‑the‑art facility in Vadodara spanning over 40,000 sq metres, with a capacity of 50,000 metric tonnes. Its global certifications (FSSC 22000, WHO GMP, ISO 9001:2015, HACCP, halal, and kosher) ensure that MSMEs sourcing from Sudeep Nutrition meet stringent regulatory standards, facilitating market access and export opportunities to the likes of the US, Canada, and Germany, to name a few. Its ingredients have found their way in products made by Nestle, PepsiCo, Abbott, Pfizer, Torrent Pharma, Mankind, and Nutrition's growth has been exemplary. Apart from having 13 global warehouses, including in markets like the US, Mexico, and Bangladesh, it reported a compounded annual growth rate of 358% in the three years ending FY24. For this reason, it was recognised as the Fastest-Growing MSME (Medium) at the ET MSME Awards 2024, India's most prestigious MSME company's impact stems from its specialised approach to customised premixes, which include blends of vitamins, minerals, amino acids, and other functional ingredients. By democratising access to sophisticated nutritional enhancement, Sudeep Nutrition has enabled micro, small, and medium food manufacturers to compete with larger corporations, levelling the field in the cutthroat food and beverage market. Its backward integration strategy has been revolutionary for India's MSME ecosystem, allowing for price benefits and operational Nutrition's technological innovations extend beyond basic mixing to advanced processing capabilities. A technology with the ability to modify fine particles into agglomerated powders with better stability and dissolution capabilities has opened new product development possibilities for MSMEs. This has been especially impactful for manufacturers of infant formulas, making it easier for them to meet international standards while maintaining cost company's role as an ecosystem enabler extends beyond product supply to comprehensive technical support. Sudeep Nutrition assists with different development challenges such as active ingredient stability, providing MSMEs with specialised knowledge that would otherwise require substantial R&D investment. This has empowered more than 1,000 enterprises worldwide to innovate and expand their portfolios without the barriers of technical expertise and capital its comprehensive approach combining technical innovation, backward integration, and extensive support, this ET MSME Award winner exemplifies how specialised MSMEs can drive ecosystem-wide transformation, proving that revolutionary change can begin with excellence in niche more winner vignettes of the ET MSME Awards , keep an eye on this space.
Business Upturn
06-05-2025
- Business
- Business Upturn
Vantage Hemp Co. Submits Application for Brazil Market Entry
By GlobeNewswire Published on May 6, 2025, 16:00 IST Greeley, Colorado, May 06, 2025 (GLOBE NEWSWIRE) — Vantage Hemp Co. ('Vantage' or 'the Company'), a globally accredited cannabinoid extractor and manufacturer, has initiated its regulatory process with ANVISA , Brazil's National Health Surveillance Agency, securing protocol numbers for its application of market authorization under the RDC 327/2019 framework and Good Manufacturing Practices Certification (CBPF) . This marks the formal start of Vantage's regulatory engagement with Brazil and lays the foundation for the Company's broader push into Latin America. Through a joint application with a Brazilian partner, Vantage has applied for approval for its initial formulation under RDC 327/2019. The bridge framework sets out rigorous requirements for the manufacturing, importation, and commercialization of cannabinoid-based products before pharmaceutical registration becomes feasible. This unique opportunity allows companies to apply for a license without having mandatory clinical studies which are often a major hurdle in the commercialization of pharmaceutical products. Vantage is positioned to meet the needs of the aspiring Brazilian market, which demands stringent pharmaceutical-grade manufacturing and full transparency across all production processes. Under the framework, companies must obtain Sanitary Authorization for each product, valid for five years, and adhere to strict quality and safety standards, including THC content limitations and mandatory physician prescriptions. As the largest healthcare market in Latin America and ranking sixth worldwide for drugs and pharmaceuticals , Brazil offers significant growth potential for cannabinoid-based therapies. As a mandatory step for compliant market entry, Vantage is pursuing CBPF certification from ANVISA, a requirement for manufacturing, importing, or distributing health-related products in Brazil. Backed by global compliance credentials such as WHO GMP, ICH Q7, and TGA PIC/S, Vantage is well-equipped to meet Brazil's regulatory standards, solidifying its role as a trusted, capable partner in the country's healthcare sector. 'Brazil represents an opportunity to support a large patient population. As a manufacturer, our goal is to empower companies in the region by providing compliant, scalable solutions,' says Deepank Utkhede, Chief Operating Officer at Vantage. 'While some companies avoid or exit international markets due to compliance hurdles, we're doubling down on our global expansion strategy, and we're committed to doing it right.' Following the receipt of protocol numbers, Vantage awaits ANVISA's review and scheduling of a site audit. The Company continues to invest in regional market readiness and client partnerships, confident that its regulatory-first approach will translate to long-term commercial success. Companies looking to register cannabinoid products in Brazil under RDC 327/2019 are encouraged to contact Vantage for manufacturing and regulatory partnership opportunities. About Vantage Hemp Co. Colorado-based Vantage Hemp Co. extracts and processes cannabinoids from industrial hemp, as well as formulates and manufactures finished products with the extracted ingredients. Vantage's contract manufacturing services offer a broad range of benefits as they operate with integrity and abide by stringent pharmaceutical production standards to provide quality products to their partners. For more information, visit . Attachment Vantage Hemp Co. Manufacturing Facility Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.
